`FOR THE SOUTHERN DISTRICT OF INDIANA
`
`ELI LILLY AND COMPANY,
`
`Plaintiff,
`
`TEVA PARENTERAL MEDICINES, INC.,
`APP PHARMACEUTICALS, LLC,
`PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA, INC., and
`BARR LABORATORIES, INC.,
`
`Defendants.
`
`Civil Action No. 1:10 cv-1376 TWP-DKL
`
`AMENDED JOINT CLAIM CONSTRUCTION STATEMENT
`
`Pursuant to the Court’s April 12, 2012, Entry in Preparation for Markman Hearing
`
`(ECF No. 109), Plaintiff Eli Lilly and Company ("Lilly") and Defendants Teva Parenteral
`
`Medicines, Inc., APP Pharmaceuticals, LLC, Pliva Hrvatska d.o.o., Teva Pharmaceuticals USA,
`
`Inc., and Barr Laboratories, Inc. (collectively "Defendants") hereby submit the following
`
`Amended Joint Claim Construction Statement.
`
`(a) The parties have exchanged lists of the claim terms, phrases, or clauses
`
`which they believe require construction, as well as proposed constructions. The parties have
`
`agreed upon the following constructions:
`
`Claim Term/Phrase
`
`Construction
`
`"an effective amount of folic acid and
`an effective amount of a methylmalonic
`acid lowering agent"
`
`"amounts of folic acid and a
`methylmalonic acid lowering agent that
`are capable of reducing the prevalence
`or severity of one or more toxicities
`associated with the administration of
`pemetrexed disodium"
`
`Sandoz Inc.
`Exhibit 1035-0001
`
`JOINT 1035-0001
`
`
`
`"methylmalonic acid lowering agent"
`
`"an effective amount of pemetrexed
`disodium"
`
`"an agent such as vitamin B 12 which
`can be used to lower the concentration
`of methylmalonic acid in a mammal"
`
`"an amount of pemetrexed disodium
`that is capable of providing a
`therapeutic benefit to the patient in
`need thereof"
`
`The parties have also agreed that the preambles of claims 1 and 12 are limiting.
`
`(b) The following chart reflects Plaintiff’ s and Defendants’ proposed
`
`constructions for the claim terms, phrases, or clauses identified by one or more of the parties as
`
`requiring construction:
`
`Claim Term/Phrase
`
`Plaintiff’s Proposed
`Construction
`
`Defendants’ Proposed
`Construction
`
`"patient"
`
`"patient (i.e., a human under
`medical care)"
`
`"vitamin B 12"
`
`"vitamin B 12 (i.e.,
`cyanocobalamin)"
`
`Indefinite
`
`(c)
`
`The parties anticipate that less than one day will be needed for the
`
`Mar kman hearing.
`
`(d)
`
`(e)
`
`The parties will not call any witnesses at the Markman hearing.
`
`The parties will first address the "patient" claim term (with a background
`
`introduction) and then will address the "vitamin B 12" claim term, with Plaintiff going first for
`
`each issue.
`
`2
`
`Sandoz Inc.
`Exhibit 1035-0002
`
`JOINT 1035-0002
`
`
`
`/s/ Jan M. Carroll
`Jan M. Carroll, No. 4187-49
`BARNES & THORNBURG LLP
`11 South Meridian Street
`Indianapolis, Indiana 46204
`(317)236-1313
`j an.caroll@btlaw, com
`
`OF COUNSEL:
`Bruce R. Genderson
`Adam L. Peflman
`Ellen E. Oberwetter
`Dov P. Grossman
`David M. Krinsky
`Megan A. Hughes
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`(202) 434-5000 (telephone)
`(202) 434-5029 (facsimile)
`
`A ttorneysfor Plaintiff
`Eli Lilly and Company
`
`Respectfully submitted,
`
`/s/ Kandi Kilkellv Hidde (w/permission)
`David O. Tittle, # 857-49
`Kandi Kilkelly Hidde, #18033-49
`BINGHAM McHALE LLP
`2700 Market Tower
`10 W. Market Street
`Indianapolis, Indiana 46204-4900
`Phone: (317) 635-8900
`Fax: (317) 236-9907
`dtittle@binghammchale, corn
`khidde@binghammchale.com
`
`OF COUNSEL:
`Daryl L. Wiesen
`Emily L. Rapalino
`GOODWIN PROCTER LLP
`53 State Street
`Boston, MA 02109
`Tel: (617) 570-1000
`dwiesen@goodwinprocter.com
`erapalino@goodwinprocter.com
`
`Michael B. Cottler
`Jonathan E. Grossman
`Eric H. Yecies
`GOODWlN PROCTER LLP
`620 Eighth Avenue
`New York, NY 10018
`Tel: (212) 813-8800
`mcottler@goodwinprocter, com
`jgrossman@goodwinprocter.com
`eyecies@goodwinprocter, com
`
`Attorneys for Defendants Teva Parenteral
`Medicines, Inc., APP Pharmaceuticals, LLC,
`Pfva Hrvatska d.o.o., Teva Pharmaceuticals
`USA, Inc. and Barr Laboratories, Inc.
`
`INDS02 JMC 1216665vl
`
`Sandoz Inc.
`Exhibit 1035-0003
`
`JOINT 1035-0003
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
